Pfizer Inc. (PFE) Tops Q1 EPS by 1c; Reaffirms Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.08 -0.52%
EPS Growth %: -12.8%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -12.8%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Pfizer Inc. (NYSE: PFE) reported Q1 EPS of $0.60, $0.01 better than the analyst estimate of $0.59. Revenue for the quarter came in at $16.5 billion versus the consensus estimate of $16.65 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer reaffirms 2026 guidance after CFO transition news
- These 2 chipmakers are key beneficiaries of power semis: Bernstein
- This oil stock is BofA's Top Pick within Integrateds and Refining sector
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
